Jazz Pharmaceuticals plc Total Debt 2009–2025
Jazz Pharmaceuticals plc (JAZZ) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $5.36B | -12.3% |
| FY 2024 | $6.11B | +6.9% |
| FY 2023 | $5.71B | -0.2% |
| FY 2022 | $5.72B | -5.4% |
| FY 2021 | $6.05B | +188.8% |
| FY 2020 | $2.09B | +30.3% |
| FY 2019 | $1.61B | +0.7% |
| FY 2018 | $1.60B | +1.0% |
| FY 2017 | $1.58B | -22.1% |
| FY 2016 | $2.03B | +70.8% |
| FY 2015 | $1.19B | -11.5% |
| FY 2014 | $1.34B | +144.1% |
| FY 2013 | $549.98M | +28.8% |
| FY 2012 | $427.07M | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | — |
| FY 2009 | $0 | — |
Source: Jazz Pharmaceuticals plc SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Jazz Pharmaceuticals plc
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeJazz Pharmaceuticals plc — frequently asked questions
What is Jazz Pharmaceuticals plc's total debt (short- plus long-term borrowings)?
Jazz Pharmaceuticals plc (JAZZ) reported total debt (short- plus long-term borrowings) of $5.36B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Jazz Pharmaceuticals plc's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.